Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v3-EN
Language French English
Date Updated 2020-03-25 2020-03-06
Drug Identification Number 02230578 02230578
Brand name TWINRIX TWINRIX
Common or Proper name Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients HEPATITIS A VACCINE, INACTIVATED HEPATITIS B SURFACE ANTIGEN HEPATITIS A VACCINE, INACTIVATED HEPATITIS B SURFACE ANTIGEN
Strength(s) 720UNIT 20MCG 720UNIT 20MCG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1's 1's
ATC code J07BC J07BC
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-12-09 2019-12-09
Estimated end date 2020-03-27 Unknown
Actual end date 2020-03-24
Shortage status Resolved Actual shortage
Company comments Inventory on allocation to support demand in private market. Supply available for public programs. Supply unavailable in the private market. Supply available for public programs.
Health Canada comments